Daewoong Pharma069620
Daewoong Pharma (069620) Preliminary Earnings, Nov 4, 2026
Filing date ·
Daewoong Pharma reported preliminary Q3 2026 results (separate): Revenue of KRW 415.8 billion (+17.1% year over year), operating profit of KRW 76.8 billion (+4…
Sign in to read this filing in detail
Continue to the filing details and any available analysis after signing in.
Filing lists and official source links are available without signing in.